logo
In-house app bridges language gap at hospital in Shizuoka

In-house app bridges language gap at hospital in Shizuoka

Asahi Shimbun3 days ago

Yoshinori Asahina of Iwata City Hospital, who developed a language app to help foreign patients, on April 23 in the city's Okubo district (Hideki Aota)
IWATA, Shizuoka Prefecture--An in-house hospital team here has developed a language app for foreign patients to prevent delays in medical care and avoid miscommunication that could cause potentially disastrous mistakes.
Like other medical institutions around Japan, Iwata City Hospital in Shizuoka Prefecture has seen an increasing number of foreign patients who lack a sufficient command of Japanese.
Since its inception in autumn 2022, the language app, called 'Furenavi,' has undergone continuous improvements and refinements.
It now provides essential explanations and confirmations before medical tests or surgical procedures in nine languages at the municipal general hospital, home to more than 30 clinical departments.
Hundreds of standard medical phrases are organized to align with the typical flow of hospital operations. With a simple tap on a tablet screen, the appropriate text—accompanied by illustrative visuals—appears, and it can also be read aloud using a built-in voice function.
For instance, for an X-ray examination, the procedure through the app might unfold as follows: staff confirm the patient's identity by asking for name and date of birth; the patient is instructed to wear only undergarments on the upper body; the patient is asked to remove bras and accessories; and finally, staff ask the patient to take a deep breath and hold it.
Furenavi displays each question and instruction in English and other supported languages, helping to ensure the process runs smoothly and without confusion.
In the past, explaining procedures to foreign patients often added considerable time to already crowded X-ray schedules. Miscommunication sometimes led to retakes, increasing patients' exposure to radiation.
Iwata is home to about 165,000 residents, including around 9,900 foreign nationals, or 6 percent of the population.
The western region of Shizuoka Prefecture, known for its concentration of motorcycle and automobile manufacturing plants, has a notably high percentage of foreign residents, particularly from Brazil.
As a result, more than one in every 20 patients at the hospital is a foreign national.
However, interpreters are not always readily available, and existing translation tools were often time-consuming with questionable accuracy.
Although not designed for two-way communication, Furenavi delivers precisely translated instructions, verified by native speakers.
It also features phrases that allow users to confirm simple responses, such as 'yes' or 'no,' through pointing.
The app was developed by 38-year-old Yoshinori Asahina of the Radiology Department. After being transferred to the department, which deals with a high number of foreign patients, he quickly recognized the communication barriers.
Drawing on his university experience building image analysis systems, Asahina teamed up with like-minded supervisors and colleagues to develop the app. Working after conventional jobs, he completed the project in about three months.
Initially available in English, Chinese and Portuguese, the app has since expanded to include six more languages, including Vietnamese, Tagalog and Indonesian, thanks to support from the prefectural government.
A newly added AI feature can even estimate a patient's likely language based on their name. As of this spring, Furenavi was also being used in emergency outpatient care and disaster response settings.
CUSTOM TAXI BOOKING SYSTEM
The success of Furenavi inspired the development of another in-house tool: a booking system for taxis that can accommodate wheelchairs and stretchers. Such vehicles are in short supply and typically face peak demand during morning hours for discharges and patient transfers.
Previously, arranging one could take more than an hour. The new system allows staff to check real-time availability online and complete bookings in just minutes.
In most public institutions and private companies, such digital tools are either purchased as commercial software or outsourced to external developers. But with limited budgets and staffing, few hospitals have the capacity to develop systems internally.
'It makes me happy to be of help to both patients and staff,' Asahina says. 'Technology only has meaning when it's put to use.'
He hopes to make the app available to health care facilities both within and beyond the prefecture.
Interest in Furenavi is growing, even among major medical equipment manufacturers. As a homegrown app, it not only helps keep costs low but also holds potential as a source of revenue.
Plans to digitize hospital operations are often scrapped due to budgetary constraints.
Shohachi Suzuki, director of Iwata City Hospital who is responsible for overseeing the municipal government's hospital operations, notes, 'We want to create environments where talented individuals and teams can flourish.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Japanese baseball legend Shigeo Nagashima dead at 89
Japanese baseball legend Shigeo Nagashima dead at 89

Kyodo News

time3 hours ago

  • Kyodo News

Japanese baseball legend Shigeo Nagashima dead at 89

KYODO NEWS - 14 hours ago - 13:36 | Sports, All Japanese baseball legend Shigeo Nagashima, a People's Honor Award recipient who rose to stardom for his on-field exploits during the country's era of rapid economic growth in the 1960s and 1970s, died Tuesday due to pneumonia, the Yomiuri Giants said. He was 89. Nagashima, who was a key player on the Giants team that won nine consecutive Central League and Japan Series titles from 1965 to 1973 and later managed the club, was a charismatic figure whose popularity transcended sports. Together with teammate Sadaharu Oh, or "O-N" as the pair were nicknamed, Nagashima became a household name at a time when the country's economy was booming and is fondly remembered by many middle-aged and older Japanese with nostalgia for those times. His retirement from playing in 1974 made the year's top 10 news stories, while the speech he gave at his retirement ceremony, in which he said "My Giants are forever immortal," has become part of Japan's popular lexicon. Over his 17-year playing career, Nagashima won the Central League batting title six times, was home run king twice and RBI leader five times. He was also a five-time CL MVP. He played in 2,186 games during his storied career, with a .305 batting average, 2,471 hits, 1,522 RBIs and 444 home runs. "I'm really shocked to hear the sudden obituary," said the 85-year-old Oh, whose 868 home runs is the Nippon Professional Baseball record. "I'm really disappointed that Mr. Nagashima, who shines brightly in the history of Japanese baseball, has departed after a long bout with illness. He taught me lots of things. I'm grateful to have been able to play with him." Known as "Mr. Giants" -- often shortened to "Mister" -- Nagashima was a flashy fielder with a flair for game-breaking batting heroics. His signature moment was his game-winning, sayonara home run in the first pro game attended by a Japanese emperor on June 25, 1959. Nagashima is credited with helping pro ball surpass Japan's traditional university game as the nation's most popular brand of baseball. When Yomiuri engineered his hiring as Japan's manager for the 2004 Olympics, players flocked to his banner. Japan swept through Asian qualifying but he was scratched from Olympic duty when he was felled by a stroke in March 2004. As Giants manager, he won five pennants, including two Japan Series titles, over 15 seasons. Although he was eventually named the Giants "Manager Emeritus," Nagashima's first tenure as manager was a rocky one. When his offense hit the skids in 1974 and the Giants just missed out on a 10th straight CL pennant, Yomiuri management jettisoned the team's most successful skipper ever, Tetsuharu Kawakami, to make room for Nagashima. In 1975, the rookie skipper led the Giants to their only last-place finish. Nagashima won CL pennants in 1976 and 1977, but not the Japan Series and was fired after the 1980 season. Nagashima returned as manager of the Giants in 1993, while a free agent system introduced at the time allowed the team to secure a steady flow of veteran front-line talent. In 1994, he won his first Japan Series pennant with a team powered by his young batting disciple and now fellow Hall of Famer, Hideki Matsui, who later joined the New York Yankees. Nagashima got the better of his old teammate Oh when the pair faced each other as managers in the 2000 Japan Series with Yomiuri prevailing 4-2 against the Pacific League-winning Daiei (now SoftBank) Hawks in the best-of-seven series. Despite being better known for wacky phrases that caught the public's attention than his communication skills, Nagashima still had a way of getting the best out of his players. Known for his cheerful character, Nagashima often created his own Japanese-English expressions, including "make drama," a phrase he used while he was Giants manager to encourage players not to give up winning even when it seemed impossible. The phrase was selected as a buzzword of 1996 after the Giants achieved a dramatic upset victory in the Central League. Born in Sakura, Chiba Prefecture near Tokyo, in 1936, Nagashima played for the Rikkyo University baseball team before joining the Giants in 1958. The CL's 1958 rookie of the year, Nagashima was the winner of the league's best nine award 17 times, the only player to win every season from his first to his last. Nagashima was inducted into the Japanese Baseball Hall of Fame in 1988 and had his No. 3 retired by the Giants. In 2013, he received the People's Honor Award, along with Matsui. The award is bestowed by Japan's prime minister for outstanding achievements in sports, entertainment and other fields. Nagashima was hospitalized in 2018 for half a year to treat a gallstone and then frequently used a wheelchair. But after receiving an offer to take part in the Tokyo Olympics' torch relay in 2021, he was determined to walk on his own feet and managed to do so with help from Oh and Matsui.

'Matcha crisis' emerges as the world falls in love with powdered green tea
'Matcha crisis' emerges as the world falls in love with powdered green tea

SoraNews24

time7 hours ago

  • SoraNews24

'Matcha crisis' emerges as the world falls in love with powdered green tea

A matcha crisis isn't fun and games like Time Crisis. It's hard and grueling like Dino Crisis . Once the hidden gem of Japanese tea ceremonies and confectionery, the carefully ground green tea known as 'matcha' has taken the world by storm with its vibrant green color, complex taste that seems to complement sweetness perfectly, and health benefits. But now, those in the industry are starting to wonder if the ingredient can handle getting this big. ▼ I'm just going to keep telling myself this is healthy because it has matcha in it. In order to achieve the best color and flavor in matcha, the plants' exposure to sunlight needs to be carefully regulated. This means the very best matcha you're likely to find is grown on a small scale with a high degree of personal attention. Even with attempts to modernize and industrialize production, there are still limitations because certain processes like growing the plants and grinding the leaves need to be done very slowly in order to be done properly. Since production can't be sped up, it would have to be expanded in order to produce more, and seeing the potential for matcha exports, the government began subsidizing green tea production a couple years ago in the hopes of focusing Japan's shrinking agricultural labor force on the coveted ingredient. Meanwhile, China stepped into the game too a while back and is currently the leading producer of matcha in the world. However, much of that is sold in their own gigantic domestic market and since they focus more on efficiency in production, it could be said that the quality is lower. ▼ These green tea plants in Saitama Prefecture are being grown in full sunlight, which means they cannot be used for matcha. The recent trade chaos caused by U.S. President Donald Trump may give Japan a competitive edge against China as Japan is expected to get a more lenient deal in the very sizable American market. Unfortunately, that probably won't make a difference, because even despite Japan's efforts at more than doubling matcha production in the past 10 years, that still won't be enough to meet the increasingly ravenous worldwide demand for the stuff. According to a tea buyer in the U.K., sales of matcha-flavored drinks have tripled in the past year alone and have even surpassed that of the classic Earl Grey there. Some in other countries like the U.S. said they have completely given up coffee in favor of matcha. A vendor in Ireland remarked that Japan will probably need to increase its production by 10 times in the next five years in order to keep up. Considering the fact that farmers of all kinds are literally a dying breed in Japan, a 10-fold increase seems unlikely unless a radical solution can be found. Many in the industry are saying we're already in the midst of what they call a 'matcha crisis' with it being hard to secure, and if both supply and demand continue on their current course we may end up in a full-blown matcha supply shock. ▼ A news report on the matcha crisis… I feel bad for those girls who probably had no idea they would appear on Japanese TV with 'MATCHA CRISIS' underneath. This could cause prices to spike hard and throw the future of matcha as we know it into turmoil. With the demand being what it is, it would seem likely that buyers in other countries would turn to more quickly produced and inferior matcha both from Japan and China, lowering the bar for a drink and ingredient once only made with an extremely high degree of craftsmanship. Many online comments in Japan felt that rising prices would preemptively help protect the integrity of Japan's more finely produced matcha and put it on the level of a high-class ingredient that it deserves. 'Japan has been selling it too cheaply. It should be marketed as a high-end product because it is.' 'This could just be a fad too, like bubble tea or tiramisu. Increasing production for now is fine, but you need to be prepared for after.' 'I don't think matcha is a passing fad because it can be used in so many ways.' 'Why don't they sell it for more?' 'This global demand probably doesn't know what good matcha tastes like, so the market will be flooded with poor-quality stuff.' 'Raise prices and make more of it so we can get some money over here.' 'Alright, who told everyone that matcha is delicious?' 'Looks like taking matcha snacks as a present for my trip to Europe was the right choice.' 'I work at a store in a tourist-heavy area and everyone is buying matcha stuff.' 'The matcha used in the tea ceremony is very carefully made. I hope this wave of commercialism doesn't affect that.' Indeed, matcha might've done well to follow the sake model in which it is marketed as a luxury drink and tends to sell for a premium overseas due to the high degree of technique that often goes into making it. But in the end, it will probably splinter off into something like chocolate where you'll have a more clear-cut range of co-existing options from the exquisitely crafted and highly expensive kinds to the stuff they use to mass produce KitKats. Source: TV Asahi News, The Guardian, Kyodo, YouTube/ANNnewsCH Photos ©SoraNews24 ● Want to hear about SoraNews24's latest articles as soon as they're published? Follow us on Facebook and Twitter!

Japan Starts Final-Stage Trial for iPS Drug for Alzheimer's

time8 hours ago

Japan Starts Final-Stage Trial for iPS Drug for Alzheimer's

News from Japan Science Technology Jun 3, 2025 22:14 (JST) Kyoto, June 3 (Jiji Press)--A Japanese team said Tuesday that it has started a final-stage clinical trial to administer to patients with familial Alzheimer's disease a drug discovered through induced pluripotent stem, or iPS, cells. This is the first final-stage trial conducted in the field of iPS drug discovery, which uses iPS cells to discover new efficacies of new and existing drugs, according to the team. The team includes members of Kyoto University's Center for iPS Cell Research and Application, or CiRA, and Towa Pharmaceutical Co., which makes and sells generic drugs. Through the trial, which began in May, the team aims to confirm the safety and efficacy of the treatment, in hopes of obtaining regulatory approval. In 2017, CiRA professor Haruhisa Inoue and others carried out an investigation to find a compound that reduces amyloid beta, which causes Alzheimer's disease, by using iPS cells. [Copyright The Jiji Press, Ltd.] Jiji Press

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store